Condition

Carcinoma, Renal Cell clinical trials and research

• 11Clinical trials
• 23Countries

Newest Carcinoma, Renal Cell clinical trials

All recruiting trials (11)

• Belzutifan plus zanzalintinib versus belzutifan alone for advanced renal cell carcinoma

  This trial tests whether adding the targeted drug zanzalintinib to belzutifan helps people with advanced renal cell carcinoma live longer and delay tumor growth compared with belzutifan plus placebo.

  Recruiting at 107 sites Phase 3 Merck Sharp & Dohme LLC · Duarte, California and 110 other locations · NCT07489495

• PF-08634404 alone and with other anticancer medicines for adults with advanced kidney cancer.

  This tests whether PF-08634404, given alone or with other cancer medicines, is safe and helps adults with locally advanced or metastatic kidney cancer who have not had prior systemic treatment.

  Recruiting at 157 sites Phase 1/2 Pfizer · Phoenix, Arizona and 182 other locations · NCT07227415

• Deep-learning tool to distinguish T1–T2 from T3 renal cell carcinoma on contrast-enhanced CT.

  This project will see if a computer model can tell whether kidney cancer is early (T1–T2) or locally advanced (T3) using contrast-enhanced CT scans before surgery.

  Recruiting Peking University First Hospital · Beijing · NCT07166445

• Using vorolanib for treating advanced kidney cancer

  This study is testing if the drug vorolanib can help people with advanced kidney cancer live longer when used as a second treatment option.

  Recruiting Jinling Hospital, China · Nanjing, Jiangsu · NCT06676527

• Evaluating bicalutamide and sunitinib for advanced kidney cancer

  This study is testing if a combination of two medications, bicalutamide and sunitinib, can help people with advanced kidney cancer who have not responded to previous treatments.

  Recruiting Phase 1/2 State University of New York at Buffalo · Buffalo, New York · NCT06222593

• Analyzing genetic mutations in kidney cells of patients with Von Hippel-Lindau disease

  This study looks at whether kidney cells from people with Von Hippel-Lindau disease have more genetic changes compared to those without the condition.

  Recruiting IRCCS San Raffaele · Milan · NCT06194669

• Creating a diagnostic model for renal cell carcinoma with tumor thrombus invasion

  This study is testing a new imaging method to help doctors better understand and treat kidney cancer that has spread into the blood vessels.

  Recruiting Peking University Third Hospital · Beijing, Beijing Municipality · NCT05589207

• Treatment of metastatic clear-cell or papillary renal carcinoma with orellanine

  This study is testing a new drug called orellanine to see if it can safely help people with advanced clear-cell or papillary kidney cancer when other treatments aren't working well.

  Recruiting at 10 sites Phase 1/2 Oncorena AB · Orange, California and 9 other locations · NCT05287945

• Dendritic cell vaccine treatment for kidney cancer

  This study is testing a new vaccine combined with a medication to see if it can help people with early-stage kidney cancer boost their immune response before surgery.

  Recruiting Phase 2 University of Pittsburgh · Pittsburgh, Pennsylvania · NCT05127824

• Testing BMS-986340 alone and with other treatments for advanced solid tumors

  This study is testing a new treatment called BMS-986340, both on its own and with other drugs, to see how safe it is for people with advanced solid tumors.

  Recruiting at 39 sites Phase 1/2 Bristol-Myers Squibb · Clovis, California and 46 other locations · NCT04895709

• NMAP blood test to help distinguish renal cell cancer from non-renal cancers

  Researchers will see if NMAP levels in blood can help separate newly diagnosed renal cancer patients from people without renal cancer.

  Recruiting Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality · NCT04113486

Related topics

Quick answers

How many Carcinoma, Renal Cell clinical trials are recruiting right now?

11, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 23 countries. The most sites are in United States (6 trials), China (5 trials), Spain (4 trials), Australia (3 trials), Germany (3 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 4, Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →